Future research could further elucidate how this pathway interacts with other systemic inflammation markers, such as the C-reactive protein to lymphocyte ratio (CLR), to deepen our understanding of the inflammatory underpinnings of depression and potentially guide new therapeutic interventions. This evidence concerns the gene CRP and depressive disorder.